<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html>
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title>Stomach/OGJ biomarkers</title>
<link rel="stylesheet" type="text/css" href="view.css" media="all">
<script type="text/javascript">
function updateDescription (frm) 
{
    var Template = ""

if (frm.A05.value !== ""){
	Template += "- HER2 IHC (for biopsy): " + frm.A05.value + "\n";
};

if (frm.A06.value !== ""){
	Template += "  - Score : " + frm.A06.value + "\n";
};

if (frm.A07.value !== ""){
	Template += "- HER2 IHC (for excision): " + frm.A07.value + "\n";
};

if (frm.A08.value !== ""){
	Template += "  - Score : " + frm.A08.value + "\n";
};

if (frm.A09.value !== ""){
	Template += "\n" + "- HER2 DISH : " + frm.A09.value + "\n";
};

if (frm.A10.value !== ""){
	Template += "  - Number of tumor cell counted : " + frm.A10.value + "\n";
};

if (frm.A11.value !== ""){
	Template += "  - Average number of HER2 signals (black) per cell : " + frm.A11.value + "\n";
};

if (frm.A12.value !== ""){
	Template += "  - Average number of CEP17 signals (red) per cell : " + frm.A12.value + "\n";
};

if (frm.A13.value !== ""){
	Template += "  - HER2/CEP17 ratio : " + frm.A13.value + "\n";
};

if (document.getElementById("A14").checked || document.getElementById("A15").checked){
	Template += "  - Other ISH abnormalities: "  + "\n";
}

if (document.getElementById("A14").checked){
	Template += frm.A14.value + "\n";
}

if (document.getElementById("A15").checked){
	Template += frm.A15.value + "\n";
}

if (frm.A27.value !== ""){
	Template += "\n" + "- EBER status : " + frm.A27.value + "\n";
}


if (frm.IHC.value !== ""){
Template += "\n" + "- DNA Mismatch Repair status: " + "\n" + "  - " + frm.IHC.value + "\n";
}

if (frm.MLH1.value !== ""){
Template += "  - MLH1 (mutL homolog 1): " + frm.MLH1.value + "\n";
}

if (frm.MSH2.value !== ""){
Template += "  - MSH2 (mutS homolog 2): "+ frm.MSH2.value + "\n";
}

if (frm.MSH6.value !== ""){
Template += "  - MSH6 (mutS homolog 6): " + frm.MSH6.value + "\n";
}

if (frm.PMS2.value !== ""){
Template += "  - PMS2 (PMS1 homolog 2): " + frm.PMS2.value + "\n";
}

if (frm.MSI.value !== ""){
Template += "\n" + "- Microsatellite instability status: " + "\n" + "  - " + frm.MSI.value + "\n";
}

if (frm.BAT25.value + frm.BAT26.value + frm.NR21.value + frm.NR24.value + frm.NR27.value!== ""){
	Template += "  - Mononucleotide Panel: " + "\n";
}	

if (frm.BAT25.value !== ""){
	Template += "    - BAT-25 : " + frm.BAT25.value + "\n";
}

if (frm.BAT26.value !== ""){
	Template += "    - BAT-26 : " + frm.BAT26.value + "\n";
}

if (frm.NR21.value !== ""){
	Template += "    - NR-21 : " + frm.NR21.value + "\n";
}

if (frm.NR24.value !== ""){
	Template += "    - NR-24 : " + frm.NR24.value + "\n";
}

if (frm.NR27.value !== ""){
	Template += "    - NR-27 : " + frm.NR27.value + "\n";
}

if (frm.BAT25.value + frm.BAT26.value + frm.D2.value + frm.D5.value + frm.D17.value!== ""){
	Template += "\n" + "  - NCI Panel: " + "\n";
}	

if (frm.BAT25.value !== ""){
	Template += "    - BAT-25 : " + frm.BAT25.value + "\n";
}

if (frm.BAT26.value !== ""){
	Template += "    - BAT-26 : " + frm.BAT26.value + "\n";
}

if (frm.D2.value !== ""){
	Template += "    - D2S123 : " + frm.D2.value + "\n";
}

if (frm.D5.value !== ""){
	Template += "    - D5S346 : " + frm.D5.value + "\n";
}

if (frm.D17.value !== ""){
	Template += "    - D17S250 : " + frm.D17.value + "\n";
}

if (frm.A20.value !== ""){
	Template += "\n" + "- PD-L1 : "+ frm.A20.value + "\n";
}

if (frm.A22.value !== ""){
	Template += "  - Positive tumor cells TPS : "+ frm.A22.value + "\n";
}

if (frm.A23.value !== ""){
	Template += "  - Combined Positive Score CPS : "+ frm.A23.value + "\n";
}

if (frm.A28.value !== ""){
	Template += "\n" + "- Claudin 18.2 : "+ frm.A28.value + "\n";
}

if (frm.A29.value !== ""){
	Template += "  - IHC 2+ tumor cells % : "+ frm.A29.value + "\n";
}

if (frm.A30.value !== ""){
	Template += "  - IHC 3+ tumor cells % : "+ frm.A30.value + "\n";
}

if (frm.A31.value !== ""){
	Template += "  - Total tumor cell positive % : "+ frm.A31.value + "\n";
}

if (frm.A32.value !== ""){
	Template += "\n" + "- Cold ischemia time : " + frm.A32.value + " min";
} else {
		Template += "\n" + "- Cold ischemic time is uncertain." ;
}

if (frm.A32.value <= 60 && frm.A32.value !== ""){
		Template += "\n" + "  - Optimal (<= 60 min)." ;
}

if (frm.A32.value > 60  && frm.A32.value !== ""){
		Template += "\n" + "  - Prolonged intervals (> 60 min)." ;
}

if (frm.A33.value !== ""){
	Template += "\n" + "- Fixation time in buffered formalin : " + frm.A33.value + " hours";
}else {
		Template += "\n" + "- Formalin fixation time is uncertain." ;
}

if (frm.A33.value < 6  && frm.A33.value !== ""){
		Template += "\n" + "  - Inadequate fixation (<6 hours)." ;
}

if (frm.A33.value >= 6 && frm.A33.value <= 72 && frm.A33.value !== ""){
		Template += "\n" + "  - Optimal fixation (6-72 hours)." ;
}

if (frm.A33.value > 72  && frm.A33.value !== ""){
		Template += "\n" + "  - Prolonged intervals (>72 hours)." ;
}

if (frm.A32.value !== "" && frm.A32.value <= 60 && frm.A33.value >= 6 && frm.A33.value <= 72){
	Template += "\n" + "- Meet requirements specified in the latest version of the ASCO/CAP guidelines." + "\n"  ;
} else if (frm.A32.value == "" || frm.A33.value == ""){
	Template += "\n" + "- Given the uncertain cold ischaemia time and/or uncertain fixation time, please interpret the above results with caution." + "\n" ;
} else if (frm.A32.value > 60 || frm.A33.value < 6 || frm.A33.value > 72){
	Template += "\n" + "- Given the suboptimal cold ischaemia time and/or suboptimal formalin fixation time, please interpret the above results with caution." + "\n" ;
}

if (frm.A19.value !== ""){
	Template += "\n" + "- Additional notes: " + "\n" + "  - " + frm.A19.value + "\n";
}

if (frm.A05.value + frm.A07.value !== ""){
	Template += "\n" + "Formalin-fixed paraffin embedded sections were assessed by IHC technique, using Ventana monoclonal HER2/neu (4B5) with Ventana BenchMark ULTRA multimer detection system.";
}

if (frm.A09.value !== ""){
	Template += "\n" + "Dual ISH was performed on formalin-fixed paraffin embedded section with the Ventana INFORM HER2 Dual ISH DNA Probe Cocktail Assay on automated system, and examined by pathologist under light microscopy.";
}

if (frm.IHC.value !== ""){
Template += "\n"+ "Formalin-fixed paraffin embedded sections were assessed by IHC technique for MLH1, MSH2, MSH6 and PMS2, using the antibodies G168-15, FE11, 44/MSH6 and A16-4, respectively.";
}

if (frm.MSI.value !== ""){
	Template += "\n" + "DNA was extracted from the tumor tissue and the normal tissue, following microdissection of formalin-fixed paraffin-embedded tissue sections. MSI was assessed using a laboratory developed method by comparing the differences in patterns of PCR products of 5 mononucleotide repeats and 3 dinucleotide repeats markers of the tumor tissue and those of the normal tissue. The MSI test is under evaluation and is not in the CAP-acredited list.";
} 

if (frm.A20.value !== ""){
	Template += "\n" + "Formalin-fixed paraffin embedded sections were assessed by IHC technique for PD-L1, using the antibody " + frm.A21.value + ". " ;
} 

if (frm.A28.value !== ""){
	Template += "\n" + "Formalin-fixed paraffin embedded sections were assessed by IHC technique for Claudin 18.2, using the antibody 43-14A (Abcam)";
}

frm.holdtext.value = Template;
}


function CopyToClipboard() {
  /* Get the text field */
  var copyText = document.getElementById("holdtext");

  /* Select the text field */
  copyText.select();

  /* Copy the text inside the text field */
  document.execCommand("copy");

  /* Alert the copied text */
  alert("Report copied to clipboard");
}
</script>
<script type="text/javascript" src="view.js"></script>
<style>
table, th, td {
  border: 1px solid silver;
  border-collapse: collapse;
  padding: 4px;
}
</style>
</head>

<body>
<img id="top" src="top.png" alt="">
	<div id="form_container">
	<div class="form_description">
		<h2><a href=".\cap\cp-gastric-HER2biomarker17-1001.pdf" target="_blank">
		<div class="tooltip">
		Stomach Biomarkers test
		<span class="tooltiptext">click to access explanations in the original CAP template</span>
		</div>
		</a></h2>

		</div>

	<form>


<p>
<table border="1">
<col width="40%">
<tr>	
<td rowspan="2" valign="top"><label class="description">- <a href=".\cap\StomachHER2_CAP_ACCP_ASCO.pdf" target="_blank">HER2 IHC, biopsy : </a></label>
(> or = 5 cancer cell clusters)
</td>
	<td><select class="element select large"  ID="A05">
		<option value=""></option>
		<option value="Cannot be determined">Cannot be determined</option>
		<option value="Negative for over-expression">Negative for over-expression</option>
		<option value="Equivocal for over-expression">Equivocal for over-expression</option>
		<option value="Positive for over-expression">Positive for over-expression</option>
	</select></td>
</tr>

<tr>
<td align="right"><label>- Score:</label>
	<select class="element select medium"  ID="A06">
		<option value=""></option>
		<option value="0 Negative(No reactivity or no membranous reactivity in any cancer cell)">0 Negative (No reactivity or no membranous reactivity in any cancer cell)</option>
		<option value="1 Negative (Cancer cell cluster, > or = 5 cells, with a faint or barely perceptible membranous reactivity irrespective of percentage of cancer cells positive)">1 Negative (Cancer cell cluster, > or = 5 cells) with a faint or barely perceptible membranous reactivity irrespective of percentage of cancer cells positive)</option>
		<option value="2 Equivocal (Cancer cell cluster, > or = 5 cells, with a weak to moderate complete, basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)">2 Equivocal (Cancer cell cluster, > or = 5 cells, with a weak to moderate complete, basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)</option>
		<option value="3 Positive (Cancer cell cluster, > or = 5 cells, with a strong complete basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)">3 Positive (Cancer cell cluster, > or = 5 cells, with a strong complete basolateral, or lateral membranous reactivity irrespective of percentage of cancer cells positive)</option>
	</select></td>
</tr>



<tr>
<td rowspan="2" valign="top"><label class="description">- <a href=".\cap\StomachHER2_CAP_ACCP_ASCO.pdf" target="_blank">HER2 IHC, excision </a> : </label>
(10% cancer cells)
</td>
	<td><select class="element select large"  ID="A07">
		<option value=""></option>
		<option value="Cannot be determined">Cannot be determined</option>
		<option value="Negative for over-expression">Negative for over-expression</option>
		<option value="Equivocal for over-expression">Equivocal for over-expression</option>
		<option value="Positive for over-expression">Positive for over-expression</option>
	</select></td>
</tr>

<tr>
<td align="right"><label>- Score:</label>
	<select class="element select medium"  ID="A08">
		<option value=""></option>
		<option value="0 Negative (No reactivity or membranous reactivity in < 10% of cancer cells)">0 Negative (No reactivity or membranous reactivity in < 10% of cancer cells)</option>
		<option value="1 Negative (Faint or barely perceptible membranous react ivity in > or = 10% of cancer cells; cells are reactive only in part of their membrane)">1 Negative (Faint or barely perceptible membranous react ivity in > or = 10% of cancer cells; cells are reactive only in part of their membrane)</option>
		<option value="2 Equivocal (Weak to moderate complete, bassolateral or lateral membranous reactivity in > or = 10% of tumor cells)">2 Equivocal (Weak to moderate complete, basolateral or lateral membranous reactivity in > or = 10% of tumor cells)</option>
		<option value="3 Positive (Strong complete, basolateral or lateral membranous reactivity in > or = 10% of cancer cells)">3 Positive (Strong complete, basolateral or lateral membranous reactivity in > or = 10% of cancer cells)</option>
	</select></td>
</tr>

<tr>
<td rowspan="6" valign="top"><label class="description">- <a href=".\cap\StomachHER2_CAP_ACCP_ASCO.pdf" target="_blank">HER2/neu oncoprotein DISH :</a> </label>
<a href=".\Biomarker-DISH-calculator.html" target="_blank">HER2 DISH calculator</a>
<br>
<a href=".\cap\her2_dish.xlsx" target="_blank">DOWNLOAD AN EXCEL FILE</a>
</td>
	<td><select class="element select large"  ID="A09">
		<option value=""></option>
		<option value="Cannot be determined">Cannot be determined</option>
		<option value="Negative for HER2 amplification">Negative for HER2 amplification</option>
		<option value="Positive for HER2 amplification">Positive for HER2 amplification</option>
	</select></td>
</tr>

<tr>
<td align="right">- Number of tumor cell counted :
<input type="text" ID="A10" class="element text small" size="10"></td>
</tr>

<tr>
<td align="right">- HER2 signals (black) per cell :
<input type="text" ID="A11" class="element text small" size="10"></td>
</tr>

<tr>
<td align="right">- CEP17 signals (red) per cell :
<input type="text" ID="A12" class="element text small" size="10"></td>
</tr>

<tr>
<td align="right">- HER2/CEP17 ratio :
<input type="text" ID="A13" class="element text small" size="10"></td>
</tr>

<tr>
<td>- Other ISH abnormalities:<br>
<input type="checkbox" id="A14" value="    - Aneusomy"><label>Aneusomy</label><br>
	<input type="checkbox" id="A15" value="    - Heterogeneous signals"><label >Heterogeneous signals</label><br>
<br>
</td>
<br>
</tr>

<tr>
<td>
<label class="">+ EBER ISH:</label>
</td>
<td>
	<select class="element select large" ID="A27">
		<option value=""></option>
		<option value="Negative for the tumor cells">Negative for the tumor cells</option>
		<option value="Positive for the tumor cells">Positive for the tumor cells</option>
		<option value="Cannot be determined">Cannot be determined</option>
		<option value="Reactivation in the lymphoid cells">Reactivation in the lymphoid cells</option>
	</select>
</td>
</tr>

<tr>
<td rowspan="5" valign="top">
<label class="">+ MMR IHC:</label>
</td>
<td>
<select class="element select large"  ID="IHC">
	<option value=""></option>
	<option value="No loss of nuclear signals of all 4 proteins: Not defective in DNA mismatch repair (non-dMMR or MMRp) and low probability of microsatellite instability-high (MSI-H).">No loss of nuclear signals of all 4 proteins: Not defective in DNA mismatch repair (non-dMMR or MMRp) and low probability of microsatellite instability-high (MSI-H).</option>
	<option value="Loss of nuclear signals of 1 or more proteins: Defective DNA mismatch repair within the tumor (dMMR). Causes could be somatic mutation or DNA methylation (sporadic), or germline alteration (Lynch syndrome).">Loss of nuclear signals of 1 or more proteins: Defective DNA mismatch repair within the tumor (dMMR). </option>
	<option value="MMR status cannot be determined by IHC.">MMR status cannot be determined by IHC.</option>
</select>
</td>
</tr>

<tr>
<td  align="right" >
<label class="">- MLH1 (mutL homolog 1):</label>
<select class="element select medium"  ID="MLH1">
	<option value=""></option>
	<option value="Intact nuclear expression in tumor cells">Intact nuclear expression in tumor cells</option>
	<option value="Loss of nuclear expression in tumor cells">Loss of nuclear expression in tumor cells</option>
	<option value="Attenuated nuclear expression in tumor cells">Attenuated nuclear expression in tumor cells</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
</select></td >
</tr>

<tr>
<td  align="right"><label class="">- MSH2 (mutS homolog 2):</label>
<select class="element select medium"  ID="MSH2">
	<option value=""></option>
	<option value="Intact nuclear expression in tumor cells">Intact nuclear expression in tumor cells</option>
	<option value="Loss of nuclear expression in tumor cells">Loss of nuclear expression in tumor cells</option>
	<option value="Attenuated nuclear expression in tumor cells">Attenuated nuclear expression in tumor cells</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
</select></td >
</tr>

<tr>
<td  align="right"><label class="">- MSH6 (mutS homolog 6):</label>
<select class="element select medium"  ID="MSH6">
	<option value=""></option>
	<option value="Intact nuclear expression in tumor cells">Intact nuclear expression in tumor cells</option>
	<option value="Loss of nuclear expression in tumor cells">Loss of nuclear expression in tumor cells</option>
	<option value="Attenuated nuclear expression in tumor cells">Attenuated nuclear expression in tumor cells</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
</select></td >
</tr>

<tr>
<td  align="right"><label class="">- PMS2 (PMS1 homolog 2):</label>
<select class="element select medium"  ID="PMS2">
	<option value=""></option>
	<option value="Intact nuclear expression in tumor cells">Intact nuclear expression in tumor cells</option>
	<option value="Loss of nuclear expression in tumor cells">Loss of nuclear expression in tumor cells</option>
	<option value="Attenuated nuclear expression in tumor cells">Attenuated nuclear expression in tumor cells</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
</select></td >
</tr>

<tr>
<td  rowspan="9" valign="top"><label class="">+ MSI status:</label></td>
<td><select class="element select large"  ID="MSI">
	<option value=""></option>
	<option value="MSI - stable (MSS)">MSI – stable (MSS)</option>
	<option value="MSI - low (MSI-L) 1% - 29% of the National Cancer Institute (NCI) or mononucleotide markers exhibit instability">MSI – low (MSI-L) 1% - 29% of the National Cancer Institute (NCI) or mononucleotide markers exhibit instability</option>
	<option value="MSI - low (MSI-L) 1 of the NCI or mononucleotide markers exhibit instability">MSI – low (MSI-L) 1 of the NCI or mononucleotide markers exhibit instability</option>
	<option value="MSI - low (MSI-L) Other (specify): ">MSI – low (MSI-L) Other (specify):</option>
	<option value="MSI - high (MSI-H) greater or equal 30% of the NCI or mononucleotide markers exhibit instability">MSI – high (MSI-H) greater or equal 30% of the NCI or mononucleotide markers exhibit instability</option>
	<option value="MSI - high (MSI-H) 2 or more of the NCI or mononucleotide markers exhibit instability">MSI – high (MSI-H) 2 or more of the NCI or mononucleotide markers exhibit instability</option>
	<option value="MSI - high (MSI-H) Other (specify): ">MSI – high (MSI-H) Other (specify):</option>
	<option value="MSI - cannot be determined.">MSI - cannot be determined.</option>
</select></td>
</tr>

<tr>
<td align="right"><label class="">BAT-25:</label>
<select class="element select medium"  ID="BAT25">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td></tr>

<tr>
<td align="right"><label class="">BAT-26:</label>
<select class="element select medium"  ID="BAT26">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td ></tr>

<tr>
<td align="right"><label class="">NR-21:</label>
<select class="element select medium"  ID="NR21">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td ></tr>

<tr>
<td align="right"><label class="">NR-24 :</label>
<select class="element select medium"  ID="NR24">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td ></tr>

<tr>
<td align="right"><label class="">NR-27 :</label>
<select class="element select medium"  ID="NR27">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td ></tr>

<tr>
<td align="right"><label class="">D2S123:</label>
<select class="element select medium"  ID="D2">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td ></tr>

<tr>
<td align="right"><label class="">D5S346:</label>
<select class="element select medium"  ID="D5">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td ></tr>

<tr>
<td align="right"><label class="">D17S250:</label>
<select class="element select medium"  ID="D17">
	<option value=""></option>
	<option value="Stable">Stable</option>
	<option value="Unstable">Unstable</option>
	<option value="Cannot be determined:">Cannot be determined:</option>
	<option value="Not performed">Not performed</option>
</select>
</td ></tr>

<tr>	
<td rowspan="4" valign="top">
<label class="">+ PD-L1 assessment :</label><br>
<a href=".\Biomarker-PDL1-calculator.html" target="_blank">PD-L1 calculator</a>
</td>
<td>
<select class="element select large"  ID="A20">
	<option value=""></option>
	<option value="Cannot be determined">Cannot be determined</option>
	<option value="Negative (CPS<10)">Negative (combined positive score CPS < 10)</option>
	<option value="Positive (combined positive score CPS > or = 10)">Positive (combined positive score CPS >= 10)</option>
</select>
</td>
</tr>

<tr>
<td align="right">
<label>- Antibody (anti-CD274) :</label>
	<select class="element select small"  ID="A21">
		<option value=""></option>
		<option value="22C3 (Dako)">22C3 (Dako)</option>
		<option value="E1L3N (Cell Signaling)">E1L3N (Cell Signaling)</option>
		<option value="Other, specify:">Other, specify:</option>
	</select>
</td>
</tr>

<tr>
<td align="right">
<label>- Positive tumor cells (TPS, %) :</label>
<input type="text" class="element text small" ID="A22" size="35">
</td>
</tr>

<tr>
<td align="right"><label>- Combined Positive Score (CPS) :</label>
<input type="text" class="element text small" ID="A23" size="35"></td>
</tr>

<tr>
<td  rowspan="4" valign="top">
<label class="">+ <a href=".\cap\How to Interpret Stains _ CLDN18.2.pdf" target="_blank">Claudin18.2 IHC</a>:</label>
</td>
<td>
	<select class="element select large" ID="A28">
		<option value=""></option>
		<option value="Negative for the tumor cells (<75% moderate to strong membranous stain)">Negative for the tumor cells (<75% moderate to strong membranous stain)</option>
		<option value="Positive for the tumor cells (> or =75% moderate to strong membranous stain)">Positive for the tumor cells (>=75% moderate to strong membranous stain)</option>
		<option value="Cannot be determined">Cannot be determined</option>
	</select>
</td>
</tr>

<tr>
<td align="right"><label>- <a href=".\cap\CLDN18.2_IHC.jpg" target="_blank">IHC 2+ tumor cells %</a> :</label>
<input type="text" class="element text small" ID="A29" size="35"></td>
</tr>

<tr>
<td align="right"><label>- <a href=".\cap\CLDN18.2_IHC.jpg" target="_blank">IHC 3+ tumor cells %</a> :</label>
<input type="text" class="element text small" ID="A30" size="35"></td>
</tr>

<tr>
<td align="right"><label>- Total tumor cells 2+ & 3+ : :</label>
<input type="text" class="element text small" ID="A31" size="35"></td>
</tr>


<tr>
<td>
<label class="description">- Cold ischemia time (min) :</label>
</td>
<td>
<input type="text" class="element text small" ID="A32" size="3">
min
</td>

<tr>
<td>
<label class="description">- Fixation time in buffered formalin :</label>
</td>
<td>
<input type="text" class="element text small" ID="A33" size="3">
hours
</td>
</tr>

</table>
</p>

<p>
<label class="description">- Additional notes:</label>
 <textarea ID="A19" class = "element textarea medium" style="border-color:grey;"></textarea> 
</p>


<br><br>
<input type="button" name="copyform" value="Check your Report" onclick="updateDescription(this.form)"/>
<br>
<TEXTAREA ID="holdtext" name="holdtext" class="textarea large" style="border-color:coral;"></TEXTAREA>

<br><br>
<!-- The button used to copy the text -->
<button onclick="CopyToClipboard()">Copy text to Clipboard</button>

<input type="reset" value="Reset Form" name="reset" style="float: right;">
</form>
<br>
<br>

<div id="footer">
Last upated 11-Apr-2025, based on <a href="https://www.cap.org/protocols-and-guidelines/cancer-reporting-tools/cancer-protocol-templates" target="_blank">US CAP cancer protocol templates</a>.<br>
html form was created on <a href="https://www.phpform.org">pForm</a>, <a href="https://www.w3schools.com/">W3 School</a>, <a href="https://stackoverflow.com/">StackOverflow</a>, and <a href="https://icons8.com">Icons8</a>.<br><br>
Anatomical Pathology Division, Queen Mary Hospital, Hong Kong.
</div>
</div>
<img id="bottom" src="bottom.png" alt="">
</body>
</html>

